Authors:
JAROSOVA M
MIHAL V
POSPISILOVA D
STARY J
ZUNA J
HOLZEROVA M
JEDLIEKOVA K
SOUSKOVA I
PREKOPOVA I
PIKALOVA Z
INDRAK K
Citation: M. Jarosova et al., CGH - COMPARATIVE GENOMIC HYBRIDIZATION IN THE ANALYSIS OF CLONAL CHANGES IN CHILDHOOD ACUTE-LEUKEMIA, Cytogenetics and cell genetics, 81(2), 1998, pp. 175-175
Authors:
ADAM Z
HAJEK R
SCUDLA Z
KUCA B
KOZA V
DRBAL J
INDRAK K
CAHOVA S
GUMULEC J
JANUSKA J
LEHANKA F
PRASKAC P
REZEK Z
VEPREK L
KREJCI M
BACOVSKY J
FRANKOVA H
SVOJGROVA M
PAPAJIK T
MARESCHOVA I
MAYER J
VORLICEK J
Citation: Z. Adam et al., THERAPY OF MULTIPLE-MYELOMA WITH HIGH-DOSE MELPHALAN AND PERIPHERAL-BLOOD STEM-CELL (PBSC) SUPPORT - FOLLOWED MAINTENANCE THERAPY WITH INTERFERON-ALPHA-2B (IFN) MONOTHERAPY OR SEQUENTIAL MAINTENANCE THERAPY IFN AND DEXAMETHASONE (DEX) - REPORT FROM ONGOING TRIAL 4W OF CZECH MYELOMA GROUP, Bone marrow transplantation, 21, 1998, pp. 740-740
Authors:
JAROSOVA M
JEDLICKOVA K
HOLZEROVA M
RAIDA L
SULOVSKA I
SOUSKOVA I
PREKOPOVA I
PIKALOVA Z
PAPAJIK T
INDRAK K
Citation: M. Jarosova et al., CGH, FISH AND CLASSICAL CYTOGENETICS AS TOOLS TO IDENTIFY CHROMOSOMALCHANGES IN PATIENTS WITH CLL, British Journal of Haematology, 102(1), 1998, pp. 192-192
Authors:
JAROSOVA M
MIHAL V
POSPISILOVA D
PIKALOVA Z
SOUSKOVA I
INDRAK K
Citation: M. Jarosova et al., CYTOGENETIC AND FISH STUDY IN 36 CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA, Cytogenetics and cell genetics, 77(1-2), 1997, pp. 319-319
Authors:
MIHAL V
HAJDUCH M
DUSEK J
JAROSOVA M
WEIGL E
PIKALOVA Z
INDRAK K
SAFAROVA M
JANOSTAKOVA A
Citation: V. Mihal et al., DIFFERENTIAL CHEMOSENSITIVITY OF LEUKEMIC-CELLS IN THE MYELOID AND LYMPHOID PHASES OF STEM-CELL LEUKEMIA (A CASE-REPORT), Neoplasma, 44(2), 1997, pp. 133-136
Authors:
KRALOVICS R
INDRAK K
STOPKA T
BERMAN BW
PRCHAL JF
PRCHAL JT
Citation: R. Kralovics et al., 2 NEW EPO RECEPTOR MUTATIONS - TRUNCATED EPO RECEPTORS ARE MOST FREQUENTLY ASSOCIATED WITH PRIMARY FAMILIAL AND CONGENITAL POLYCYTHEMIAS, Blood, 90(5), 1997, pp. 2057-2061
Authors:
FABER F
INDRAK K
NEUWIRTOVA R
MOCIKOVA K
KUVIKOVA A
JAROSOVA M
PIKALOVA Z
Citation: F. Faber et al., IMMUNOTHERAPY WITH LOW-DOSE INTERLEUKIN-2 IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES RAEB AND RAEB-T, Blood, 90(10), 1997, pp. 4036-4036
Authors:
FABER E
RIEGROVA D
JAROSOVA M
HUBACEK J
SLEZAK P
PIKALOVA Z
HAMAL P
INDRAK K
Citation: E. Faber et al., ABDOMINAL ZYGOMYCOTIC - THROMBOANGIITIS IN A PATIENT WITH AML AND T(1-13-14), Annals of hematology, 73(4), 1996, pp. 195-198
Authors:
DIVOKY V
INDRAK K
MRUG M
BRABEC V
HUISMAN THJ
PRCHAL JT
Citation: V. Divoky et al., A NOVEL MECHANISM OF BETA-THALASSEMIA - THE INSERTION OF L1 RETROTRANSPOSABLE ELEMENT INTO BETA-GLOBIN IVS-II, Blood, 88(10), 1996, pp. 580-580
Authors:
DIVOKY V
BAYSAL E
ONER R
CURUK MA
WALKER ELD
INDRAK K
HUISMAN THJ
Citation: V. Divoky et al., THE T-]C MUTATION AT POSITION -GLOBIN GENE IS A RARE POLYMORPHISM THAT DOES NOT CAUSE A BETA-THALASSEMIA AS PREVIOUSLY ASCRIBED(96 OF THE UNTRANSLATED REGION 3' TO THE TERMINATING CODON OF THE BETA), Human genetics, 93(1), 1994, pp. 77-78
Authors:
DIVOKY V
SVOBODOVA M
INDRAK K
CHROBAK L
MOLCHANOVA TP
HUISMAN THJ
Citation: V. Divoky et al., HB HRADEC-KRALOVE (HB HK) OR ALPHA(2)BETA(2)115(G17)ALA-!ASP, A SEVERELY UNSTABLE HEMOGLOBIN-VARIANT RESULTING IN A DOMINANT BETA-THALASSEMIA TRAIT IN A CZECH FAMILY, Hemoglobin, 17(4), 1993, pp. 319-328
Citation: K. Indrak et al., A NEW ALPHA-THALASSEMIA-2 DELETION RESULTING IN MICROCYTOSIS AND HYPOCHROMIA AND INVITRO CHAIN IMBALANCE IN THE HETEROZYGOTE, American journal of hematology, 43(2), 1993, pp. 144-145